Page last updated: 2024-11-12

aegeline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aegeline: main alkaloid of aegle Marmelos correa leaves; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AeglegenusA plant genus of the family RUTACEAE.[MeSH]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]
Aegle marmelosspecies[no description available]RutaceaeA plant family in the order Sapindales that grows in warmer regions and has conspicuous flowers.[MeSH]

Cross-References

ID SourceID
PubMed CID15558419
CHEBI ID196319
MeSH IDM0560970

Synonyms (33)

Synonym
ACON1_000768
MEGXP0_001339
NCGC00169378-01
BRD-A95848471-001-01-3
(+/-)-aegeline
(e)-n-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enamide
CHEBI:196319
n-(2-hydroxy-2-(4-methoxyphenyl)ethyl)cinnamamide
456-12-2
aegeline
60t59ln3sg ,
aegelin
2-propenamide, n-(2-hydroxy-2-(4-methoxyphenyl)ethyl)-3-phenyl-, (e)-
(+-)-aegeline
unii-60t59ln3sg
(+-)-egeline
n-(2-hydroxy-2(4-methoxyphenyl)ethyl)-3-phenyl-2-propenamide
n-(2-hydroxy-2(4-methoxyphenyl)ethyl)-3-phenyl-2-propenamide, (e)-
2-propenamide, n-(2-hydroxy-2-(4-methoxyphenyl)ethyl)-3-phenyl-, (e)-(+/-)-
egeline [usp-rs]
egeline
AKOS022174795
(2e)-n-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enamide
J-523534
n-cinnamoyl-?-hydroxy-4-methoxyphenyl-aethylamin
ncgc00169378-02!(e)-n-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenylprop-2-enamide
CS-W022896
(e)-n-[2-hydroxy-2-(4-methoxyphenyl)ethyl]cinnamamide
AMY36792
Q27263252
n-[2-hydroxy-2(4-methoxyphenyl) ethyl]-3-phenyl-2-propenamide
HY-W042156
DTXSID101318019

Research Excerpts

Overview

Aegeline is an alkaloidal-amide, isolated from the leaves of Aegle marmelos. It has shown antihyperglycemic as well as antidyslipidemic activities in the validated animal models of type 2 diabetes mellitus.

ExcerptReferenceRelevance
"Aegeline (AGL) is a natural alkaloidal amide mainly isolated from the leaves and fruits of tropical plant "( Metabolic activation of aegeline mediated by CYP2C19.
Li, J; Li, W; Peng, Y; Tian, M; Yang, L; Zheng, J; Zhou, S, 2021
)
2.37
"Aegeline is an alkaloidal-amide, isolated from the leaves of Aegle marmelos and have shown antihyperglycemic as well as antidyslipidemic activities in the validated animal models of type 2 diabetes mellitus. "( Aegeline from Aegle marmelos stimulates glucose transport via Akt and Rac1 signaling, and contributes to a cytoskeletal rearrangement through PI3K/Rac1.
Gautam, S; Ishrat, N; Narender, T; Singh, R; Srivastava, AK, 2015
)
3.3

Toxicity

ExcerptReferenceRelevance
"From February 2012 to February 2014, FDA received 114 reports of adverse events of all kinds involving consumers who ingested OxyELITE Pro."( The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.
DeBeck, HJ; Gensheimer, K; Klontz, KC; Lance, SE; LeBlanc, P; Mogen, KM; Monahan, C; Sabo, JL; Salter, M; Seelman, SL; Steigman, DS; Wolpert, BJ,
)
0.13
"Vigilant surveillance is required for adverse events linked to the use of dietary supplements."( The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.
DeBeck, HJ; Gensheimer, K; Klontz, KC; Lance, SE; LeBlanc, P; Mogen, KM; Monahan, C; Sabo, JL; Salter, M; Seelman, SL; Steigman, DS; Wolpert, BJ,
)
0.13
" Besides, aegeline also prevented growth block in cells expressing the more toxic A53T α-synuclein mutant."( Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast.
Bharate, SB; Chaudhuri, B; Derf, A; Sharma, A, 2019
)
2.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (84.62)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.86 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index40.31 (26.88)
Search Engine Supply Index2.17 (0.95)

This Compound (31.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (7.14%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]